No material LLY-specific news briefings with verified dates were available in the 30-day window preceding this report's generation date of 5 October 2026. A broader macro briefing dated 27 September 2026 noted that the Strait of Hormuz crisis deepened as diplomatic efforts to reopen the waterway collapsed, with Iran transmitting a seven-day peace proposal to Washington through Qatari mediators. An earlier briefing dated 14 September 2026 recorded Brent crude at $108 per barrel, up approximately 3% on the day, amid intensifying Middle East supply disruptions. These developments represented the dominant macro backdrop across the reporting period.
Eli Lilly's trailing twelve-month revenue as of 30 June 2026 stood at $79.67 billion, reflecting year-over-year growth of 47.7%. Net income for the same period was $26.71 billion, with a net margin of 33.5%. EPS grew 26.2% year-over-year. The company reported cash of $8.95 billion against total debt of $54.91 billion. The price-to-earnings ratio stood at 38.35 as of the filing date [SEC 10-Q - LLY - 2026-06-30].
Five insider transactions were recorded in October 2026, with a mixed net direction and a net reported value of zero [SEC Form 4 - LLY - 2026-10]. Institutional ownership disclosures showed material position changes across several major filers. Citadel added 46% to its position, AQR Capital added 21%, and Bridgewater added 23%. ARK Invest recorded a 509% increase in its reported position. Millennium reduced its position by 14% [SEC 13F - Citadel, AQR Capital, Bridgewater, ARK Invest, Millennium - Q3 2026].
The 10-year US Treasury yield stood at 5.24% and the 2-year at 4.78%, producing a normal yield curve configuration as of the report date [FRED DGS10; FRED DGS2]. The elevated rate environment reflects the broader macro context in which large-cap equities, including pharmaceutical names, continued to operate during this period.
This report was triggered by material institutional position changes disclosed in the most recent 13F filings, which showed divergent activity among prominent asset managers with respect to their reported LLY holdings.